Form 4: Tenax Therapeutics CEO Reports Stock Transaction
Insider Transaction (Form 4)
Christopher Thomas Giordano, CEO and a Director of Tenax Therapeutics, Inc., reported multiple transactions in common stock on July 13, 2026.
Summary
- Option exercise/conversion: acquired 219 Common Stock at $3.55 ($777) on July 13, 2026; holds 2,824 after (Direct).
- Option exercise/conversion: acquired 8,500 Common Stock at $5.94 ($50,490) on July 13, 2026; holds 11,324 after (Direct).
- Option exercise/conversion: disposed of 219 Stock Option (right to buy) on July 13, 2026; holds 218 after (Direct).
- Option exercise/conversion: disposed of 8,500 Stock Option (right to buy) on July 13, 2026; holds 1,241,500 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Christopher Thomas Giordano — Director, Officer (CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-13 | Option exercise/conversion | Common Stock | 219 | $4 | $777 | 2,824 |
| 2026-07-13 | Option exercise/conversion | Common Stock | 8,500 | $6 | $50.5K | 11,324 |
| 2026-07-13 | Option exercise/conversion | Stock Option (right to buy) | 219 | — | — | 218 |
| 2026-07-13 | Option exercise/conversion | Stock Option (right to buy) | 8,500 | — | — | 1,241,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-13 | Option exercise/conversion (219 shares) |
| 2026-07-13 | Option exercise/conversion (8,500 shares) |
| 2026-07-13 | Option exercise/conversion (219 shares) |
| 2026-07-13 | Option exercise/conversion (8,500 shares) |
Keywords
insider transaction, Form 4, TENX, TENAX THERAPEUTICS, INC., neutral, Christopher Thomas Giordano
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.